The Global Swab and Viral Transport Medium market Size is evaluated at USD 749 Million in 2021 and is anticipated to reach USD 982 Million by 2030 with a CAGR of 3% from 2022 to 2030.

The FDA is essential to defending the US against dangers like the Coronavirus Disease 2019 (COVID-19) pandemic and newly developing infectious diseases. The FDA is dedicated to offering prompt advice to support pandemic response activities.

The FDA is providing this advice to help make devices for transporting specific clinical specimens more readily available, including transport media that can be used to transport specific clinical specimens for use with molecular reverse transcriptase-polymerase chain reactions (RT-PCR) For the period of the COVID-19 public health emergency, SARS-CoV-2 assays or antigen-detection diagnostic SARS-CoV-2 assays (hence generally referred to as SARS-CoV-2 assays) are used.

Market Dynamics

While the pandemic is presently driving market expansion, industry participants are placing more and more attention on the creation of sophisticated testing procedures, such as molecular essay experiments and quick antigen testing, which will help to maintain demand in the long run.

Microbiologists can collect, transport, and preserve biological samples intended for testing and research with the help of swabs and viral transport medium. Governments from all over the world are collaborating closely with healthcare technology providers to enable widespread testing for COVID-19 infections in an effort to stop the infection's spread.

While the pandemic is currently fueling the market's growth, major companies are increasingly concentrating on the creation of better testing methods, like quick antigen testing and molecular assay studies, that will support demand in the long run. Additionally, to retain and later identify the viral growth, microbiological culture swabs and transport media are needed for the advancement in diagnostics of these viruses. Swab and viral transport medium were therefore more in demand as a result of these investigations.

Innovative kits incorporating vials, double-ended flocked swabs, medicines, and other products that prevent bacterial or fungal contamination are being produced by companies in the swab and viral transport medium sector. They are concentrating on a better Hanks solution formulation to stop the growth of bacterial and fungal flora.

In order to obtain awareness on a global scale, businesses in the swab and viral transport medium market are working harder to create FDA (Food & Drug Association)-approved products. For instance, the Universal Transport Medium (UTM)®, which is suited for the collection, maintenance, and long-term freeze storage of clinical specimens, has been introduced by Hardy Diagnostics, an FDA-licensed producer of medical devices for microbiological testing. Researchers strongly desire long-term survival of organisms in swab and viral transfer medium.

Market Insights

The three categories of the global swab and viral transport medium market are product type, indication, end-user, and region. product type segment can be further divided into viral transport medium (glycerol transport medium and tissue culture medium), virus swabs (combined nasal & throat swabs, culture swabs, deep nasal swabs, nasopharyngeal swabs, and vaginal swabs). On the basis of indication, the segmentation includes adenovirus, COVID-19, herpes simplex virus, influenza, mumps virus, respiratory syncytial virus, rhinovirus, varicella-zoster virus, and other indications. Furthermore, end-user sub-segment is split into hospitals & clinics, diagnostic laboratories, microbiology laboratories, and others.

Global Swab and Viral Transport Medium Market Geographical Competition

The North American, European, Latin American, Asian Pacific, and Middle Eastern & African regions make up the five geographical segments of the worldwide swab and viral transport medium market. The swab and viral transfer medium market is anticipated to gain the greatest market share in North America. The rising number of diagnostic tests and the presence of significant market players in this area have a beneficial effect on the expansion of the local market. Because of the increased need for swabs and viral transport medium during COVID-19, laboratories and research institutions are putting a lot of effort into testing new corona virus vaccines. On the other hand, in the upcoming years, Asia Pacific is anticipated to grow at a significant rate in the global swab and viral transport medium market. The rising demand for specimen collection kits in the APAC region is one of the key factors driving the expansion of the regional market.

Global Swab and Viral Transport Medium Industry Segment Analysis

Swab and Viral Transport Medium Market By Product Type

·        Virus Swabs

o   Combined Nasal & Throat Swabs

o   Culture Swabs

o   Deep Nasal Swabs

o   Nasopharyngeal Swabs

o   Vaginal Swabs

·        Viral Transport Medium

o   Glycerol Transport Medium

o   Tissue Culture Medium

Swab and Viral Transport Medium Market By Indication

·        Adenovirus

·        Covid-19

·        Herpes Simplex Virus

·        Influenza

·        Mumps Virus

·        Respiratory Syncytial Virus

·        Rhinovirus

·        Varicella-Zoster Virus

·        Others

Swab and Viral Transport Medium Market By End-User

·        Diagnostic Laboratories

·        Hospitals & Clinics

·        Microbiology Laboratories

·        Others 

Swab and Viral Transport Medium Market Leading Companies

This section of the study honors the market's top vendors BTNX, Becton Dickinson and Company, COPAN Diagnostics, Deltalab, DiaSorin Molecular LLC, Hardy Diagnostics, HiMedia Laboratories, Medical Wire & Equipment (MWE), Puritan Medical Products, Thermo Fisher Scientific, Titan Biotech Ltd., YOCON Biology, and VIRCELL S.L.

Swab and Viral Transport Medium Market Regions